CN Patent

CN111440771A — 一种含有clcn2纯合突变的白质脑病患者特异诱导多能干细胞系

Assigned to Third Affiliated Hospital Sun Yat Sen University · Expires 2020-07-24 · 6y expired

What this patent protects

本发明公开了一种含有CLCN2纯合突变(c.2257C>T)的白质脑病患者特异诱导多能干细胞系。收集CLCN2基因突变患者的尿液，分离和培养尿液细胞，尿液细胞重编程为诱导多能干细胞，获得含有CLCN2纯合突变(C.2257C>T)的白质脑病患者特异诱导多能干细胞系。该诱导多能干细胞的STR与CLCN2患者的相同，表达多潜能分子标签，体内具有形成畸胎瘤能力，可为CLCN2突变相关疾病的发病机制及治疗研究提供新的生物材料和细胞模型工具。

USPTO Abstract

本发明公开了一种含有CLCN2纯合突变(c.2257C>T)的白质脑病患者特异诱导多能干细胞系。收集CLCN2基因突变患者的尿液，分离和培养尿液细胞，尿液细胞重编程为诱导多能干细胞，获得含有CLCN2纯合突变(C.2257C>T)的白质脑病患者特异诱导多能干细胞系。该诱导多能干细胞的STR与CLCN2患者的相同，表达多潜能分子标签，体内具有形成畸胎瘤能力，可为CLCN2突变相关疾病的发病机制及治疗研究提供新的生物材料和细胞模型工具。

Drugs covered by this patent

Patent Metadata

Patent number
CN111440771A
Jurisdiction
CN
Classification
—
Expires
2020-07-24
Drug substance claim
No
Drug product claim
No
Assignee
Third Affiliated Hospital Sun Yat Sen University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.